A new study published in JAMA Neurology suggests that commonly prescribed medications for anxiety, depression, and sleep ...

A new study links common mental health drugs to a higher ALS risk. The research focused on anxiolytics, hypnotics, and ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

Ms Siti Nur Sabrina Anis, 26, had to swop one set of wheels for another – her Yamaha motorcycle for a motorised wheelchair.

Cannabidiolic acid (CBDA), a minor non-psychoactive cannabinoid, has demonstrated greater neuroprotective effects than ...

In May 2024, physicians notified Keil that he had amyotrophic lateral sclerosis (ALS ... but there are methods to lessen the severity of symptoms and improve quality of life via early treatments and ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness as well as effective treatments.

Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to environmental factors.

Amyotrophic lateral sclerosis (ALS, also known as motor neuron disease) is a relentlessly progressive and fatal neurodegenerative disorder caused by motor neuron death in the brain and spinal cord.

Experimental drug Ulefnersen offers hope for rare, early-onset Amyotrophic lateral sclerosis (ALS) in clinical trials.

MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)LYON, France-- (BUSINESS WIRE)-- Regulatory News: These encouraging ...